Tesamorelin 10mg
Be the first to share your experience
Help other researchers by sharing how this product performed in your work.
What You Should Know
Targets dangerous belly fat
Clinical studies show Tesamorelin significantly reduces visceral fat — the deep belly fat around your organs that is linked to heart disease, diabetes, and other serious health problems.
Backed by extensive clinical research
Tesamorelin is one of the few GH-releasing peptides with large-scale clinical trial data, giving it a stronger evidence base than most similar compounds.
May improve brain function
Emerging research has found cognitive benefits including better memory, sharper thinking, and faster information processing in study participants.
A clinically studied GHRH analog researched for growth hormone stimulation and visceral adipose tissue.
Tesamorelin is one of the few GH-releasing peptides with extensive clinical trial data. It works by stimulating the pituitary gland to produce growth hormone at more youthful levels.
Clinical studies have observed significant reductions in visceral adipose tissue (the deep abdominal tissue surrounding organs) in treated subjects, without the side effects associated with direct GH administration.
Emerging research has observed cognitive benefits in treated subjects, including improvements in executive function, verbal memory, and information processing speed.
Quality: ≥99% (HPLC) · Third-party tested
All Elystra Bio products are third-party tested for identity, purity, and potency. Certificates of analysis are available upon request.
Modified GHRH analog — visceral adiposity & GH research.
“Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that includes a trans-3-hexenoic acid modification. This structural enhancement provides increased stability and potency compared to native GHRH. It is the only GHRH analog to receive FDA recognition, primarily studied in the context of visceral adiposity and metabolic research.”
Description
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that includes a trans-3-hexenoic acid modification. This structural enhancement provides increased stability and potency compared to native GHRH. It is the only GHRH analog to receive FDA recognition, primarily studied in the context of visceral adiposity and metabolic research.
Related products
-
Research Profile
A selective growth hormone secretagogue that stimulates GH release without affecting cortisol or prolactin levels.
≥99% (HPLC) · Third-party tested
Ipamorelin 10mg
Research Use Only $59.99 Add to cart -
Research Profile
A growth hormone-releasing hormone (GHRH) analog that stimulates natural growth hormone production from the pituitary gland.
≥99% (HPLC) · Third-party tested
Sermorelin 10mg
Research Use Only $79.99 Add to cart -
Research Profile
A coenzyme essential for cellular energy production, DNA repair, and healthy aging — levels naturally decline with age.
≥99% (HPLC) · Third-party tested
NAD+ 1000mg
Research Use Only $164.99 Add to cart -
Research Profile
A next-generation amylin receptor agonist studied for appetite regulation and metabolic signaling.
≥99% (HPLC) · Third-party tested
Cagrilintide 5mg
Research Use Only $59.99 Add to cart
For research purposes only. Not for human consumption. All products are third-party tested.
Reviews
There are no reviews yet.